Johann de Bono is Regius Professor
The ICR has appointed Professor Johann de Bono as Regius Professor of Cancer Research in recognition of his work in the clinical development of personalised treatments.
Share this article
Gene testing helps guide prostate treatment
The ICR was among 12 institutions to be awarded a prestigious Regius Professorship by the Queen to mark her 90th birthday in June 2016.
Professor de Bono specialises in developing new molecularly targeted therapies and improving treatments for prostate cancer patients.
Over the past decade, he has been involved in developing more than 100 potential new drugs, several of which are now available to patients.
He has led pivotal clinical trials for prostate cancer drugs that have benefited hundreds of thousands of men, and is currently involved in more than 30 early-stage trials of new treatments.